Mary Ya-Ping Yeh

Title: Mary Ya-Ping Yeh: Innovator in Protein Detection and Nephropathy Diagnosis

Introduction

Mary Ya-Ping Yeh is a prominent inventor based in Taipei, Taiwan. She has made significant contributions to the field of medical diagnostics, particularly in the detection of protein fragments related to nephropathy. With a total of 5 patents to her name, her work has the potential to improve patient outcomes in kidney-related diseases.

Latest Patents

One of her latest patents is a method of detecting a urine protein fragment and a serum protein fragment. This method describes the detection of a protein fragment in both urine and serum samples, specifically targeting urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, or serum osteopontin fragments. The samples are obtained from the same individual, enhancing the accuracy of the diagnosis. Another significant patent focuses on biomarkers associated with nephropathy. This patent emphasizes the use of urine biomarkers for diagnosing nephropathy, monitoring its progress, and assessing the efficacy of treatments. The biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and various combinations.

Career Highlights

Mary has worked with notable organizations such as the Industrial Technology Research Institute and Bio Preventive Medicine Corporation. Her experience in these institutions has allowed her to develop innovative solutions in the medical field.

Collaborations

Throughout her career, Mary has collaborated with esteemed colleagues, including Wei-Ya Lin and Tzu-Ling Tseng. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Mary Ya-Ping Yeh is a trailblazer in the field of protein detection and nephropathy diagnosis. Her innovative patents and collaborations highlight her commitment to improving healthcare through scientific advancements.